Clinical Features	Time to Death		AGE		NEOPLASM.DISEASESTAGE		PATHOLOGY.T.STAGE		PATHOLOGY.N.STAGE		PATHOLOGY.M.STAGE		GENDER		HISTOLOGICAL.TYPE		COMPLETENESS.OF.RESECTION		NUMBER.OF.LYMPH.NODES	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Wilcoxon-test_P	Wilcoxon-test_Q
APC	56 (81%)	13	0.09057	1	0.82977	1	0.4347	1	0.26414	1	0.74801	1	0.38451	1	0.76371	1	0.65543	1	0.71375	1	0.48047	1
TP53	44 (64%)	25	0.10455	1	0.95517	1	0.76956	1	0.080889	1	1	1	1	1	1	1	0.42014	1	0.63952	1	0.95994	1
KRAS	38 (55%)	31	0.23556	1	0.61213	1	0.62854	1	0.096409	1	0.83177	1	0.32689	1	0.32899	1	0.26979	1	0.04104	1	0.59345	1
SMAD4	8 (12%)	61	0.25518	1	0.67987	1	0.88373	1	1	1	0.64711	1	0.3268	1	1	1	0.0058118	0.697	1	1	0.53212	1
FBXW7	9 (13%)	60	0.76359	1	0.72138	1	0.3442	1	0.57953	1	0.19934	1	0.33783	1	0.72158	1	1	1	0.6334	1	0.15463	1
NRAS	5 (7%)	64	0.69777	1	0.021184	1	0.95468	1	0.051789	1	0.53112	1	0.55453	1	1	1	1	1	1	1	0.7902	1
ARID1A	5 (7%)	64	0.81893	1	0.82584	1	0.59927	1	0.03378	1	0.34277	1	1	1	0.64626	1	1	1	1	1	0.086163	1
RBM10	4 (6%)	65	0.035903	1	0.082825	1	0.16309	1	0.6811	1	0.02829	1	0.097496	1	1	1	0.41656	1	0.44085	1	0.023046	1
TCF7L2	7 (10%)	62	0.88155	1	0.92868	1	0.9675	1	0.7948	1	0.84823	1	0.26617	1	1	1	1	1	0.27505	1	0.95446	1
ERBB2	4 (6%)	65	0.38065	1	0.73834	1	0.76756	1	1	1	0.45292	1	1	1	0.12684	1	1	1	1	1	0.1285	1
KIAA1804	9 (13%)	60	0.64363	1	0.34922	1	0.74474	1	0.70694	1	1	1	1	1	1	1	1	1	1	1	0.64494	1
CCDC88C	3 (4%)	66	0.521	1	0.89458	1	0.24879	1	0.18195	1	0.52421	1	1	1	1	1	1	1	1	1	0.87903	1